Are You Helping Cell & Gene Therapy Developers Build Better Analytical Workflows?

Analytical development teams are under pressure to deliver more than data. They need potency assays that withstand regulatory scrutiny, characterization methods that keep pace with increasingly complex therapies, and analytical control strategies that remain effective from early development through commercialization. To do this, many teams are evaluating new technologies, specialist partners, and outsourcing models that can improve efficiency, strengthen decision-making, and accelerate development timelines.

The 8th Cell & Gene Therapy Analytical Development Summit brings together the analytical development, QC and CMC leaders actively tackling these challenges. Attendees join to benchmark approaches, uncover practical solutions, learn from real-world case studies, and discover emerging analytical technologies they can apply within their own programs.

Whether you provide CDMO services, specialist CRO expertise, analytical instrumentation and characterization solutions, or advanced sequencing and analytical technologies, this is your opportunity to connect with a highly engaged audience looking for partners that can help them generate better analytical data and advance therapies with confidence.

sponsor (1)

What to Expect?

Meet the Full Analytical Buying Committee

Engage with both the scientists developing and troubleshooting assays daily and the leaders responsible for technology selection, outsourcing, platform strategy, and commercialization decisions.

Build Relationships That Last Beyond the Event

Develop meaningful connections through workshops, roundtables, networking sessions, and peer discussions designed to encourage deeper technical conversations and future collaboration.

Demonstrate Scientific Expertise

Showcase your capabilities through thought leadership presentations, panel discussions, workshops, and technical conversations that analytical teams consistently tell us they value over traditional sales-led interactions.

Gain Unfiltered Market Intelligence

Hear first-hand how developers are approaching potency assays, tech transfer, characterization, NGS implementation, automation, AI, and commercial readiness, enabling you to better align your offerings with market needs.

Key Interest Areas

Our attendees from CGT analytical and QC teams are looking for service and solution providers with capabilities in the below areas but not limited to:

CDMOs / CMOs

Contract development and manufacturing partners supporting manufacturing, analytical development, assay validation, tech transfer, QC, and commercialization activities.

CROs

Specialist analytical partners providing assay development, qualification, validation, bioanalytical testing, potency testing, characterization, and regulatory support.

Instrument Providers & Analytical Services / Characterization

Providers of analytical instruments, reagents, software, characterization platforms, flow cytometry, PCR, mass spectrometry, and related scientific services.

Sequencing & Advanced Analytical Technology Providers

Companies offering NGS, long-read sequencing, digital PCR, advanced genomic characterization, genome integrity analysis, bioinformatics, and related technologies.

Hear What Our Past Sponsors Have to Say

Countable Labs

The attendees were all important contacts to make. It was a small but focused and valuable conference for us. We got to present our technology to the people who will benefit most from working with us.

Senior Account Manager, Countable Labs

Beckman Coulter

Great connections with leaders in the field

Global Marketing Development Manager, Beckman Coulter

LICORbio

The level of engagement from attendees was fantastic. Every attendee was a target customer for me. They provided me with honest feedback that is going to help me refine and improve my marketing messaging.

Senior Manager, Global Sales Enablement & Training, LICORbio

Audience Composition

Company Type

8th CGT Analytical Development Summit 2026 audience breakdown

*Statistics taken from the 7th Cell Therapy Analytical Development Summit & the 7th Gene Therapy Analytical Development Summit

Attendee Seniority

8th-CGT-Analytical-Development-Summit-2026-audience-breakdown-2-e1786963958547

Available Inventory

We have a range of inventory from standard booth and speaking slots to more bespoke deliverable such as badges, exclusive dinners and tours to help elevate your brand:

Presenting Slots at 6th Rare & Genetic Kidney Disease DD Summit
Leading Innovation at 6th Rare & Genetic Kidney Disease DD Summit
Audience engaging at 6th Rare & Genetic Kidney Disease DD Summit
24-1-768x432
Networking at 6th Rare & Genetic Kidney Disease DD Summit
Networking at 6th Rare & Genetic Kidney Disease DD Summit
Exhibiting at 6th Rare & Genetic Kidney Disease DD Summit
Networking at 6th Rare & Genetic Kidney Disease DD Summit

Attending Companies Include

Get in Touch

Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us at sponsor@hansonwade.com if you would like to get involved and discuss a bespoke package suited to your needs.

Malik Mellal

Partnerships Director

competitive edge
Maintain Your Competitive Edge

Position your brand alongside the companies shaping the future of cell & gene therapy analytical development.

sponsor (1)
Network With Decision-Makers

Engage with both hands-on scientists and senior leaders responsible for analytical, QC, CMC, and outsourcing decisions.

showcase capabilities
Showcase Your Capabilities

Demonstrate your expertise through bespoke thought leadership, exhibition, and networking opportunities tailored to your goals.